ReviewNaunyn-Schmiedeberg's archives of pharmacology2026
Baicalin: bridging traditional medicine and modern science in food and functional applications.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Modulation of the gut microbiota by traditional Chinese medicine to attenuate chemotherapy-induced toxicity in gastric cancer: a review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Review
- Baicalin and CNS-related diseases: new insights into neuroprotective potentials based on underlying mechanisms.Biochemistry and biophysics reports · 2026Review
- Baicalin as a multifunctional flavone glycoside: pharmacological mechanisms, ADME profile, and therapeutic potential.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- An integrated nano-delivery platform via baicalein-loaded polydopamine-MOF for enhanced neuroprotection against retinal ischemia reperfusion injury.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Baicalin, a bioactive flavonoid derived from Scutellaria baicalensis Georgi, epitomizes the ancient Chinese "medicine-food homology" (MFH) theory, serving dual roles in therapeutics and functional foods. This review synthesizes recent advances (2018-2024) on baicalin's multifaceted biological activities, pharmacological mechanisms, and emerging applications in food science. Structurally characterized by a flavone-7-O-glucoside backbone, baicalin exerts potent anti-inflammatory, antioxidant, antitumor, antiviral, and antimicrobial effects through modulation of key pathways, including NF-κB, Nrf2, TLR4/MyD88, and PI3K/AKT. Its anti-inflammatory action involves suppression of NLRP3 inflammasome activation and cytokine release, while its antioxidant capacity is mediated by Nrf2-driven detoxification. In food systems, baicalin enhances oxidative stress resistance in aquaculture feeds and improves hydrophobic nutraceutical bioavailability via nanoparticle encapsulation. Challenges such as low water solubility (0.5 mg/mL) and pH-dependent stability are addressed through innovative formulations, such as β-cyclodextrin complexes and ternary solvent systems, which enhance solubility by sevenfold. Network pharmacology and bioinformatics analyses reveal baicalin's multi-target engagement in cardiovascular, metabolic, and neurological disorders, underscoring its therapeutic versatility. Clinically, baicalin demonstrates cardioprotective, antidiabetic, and neuroprotective efficacy, while nano-delivery systems-including liposomes and metal-organic frameworks-overcome bioavailability limitations. This review bridges traditional MFH principles with cutting-edge research, positioning baicalin as a promising candidate for functional food development and preventive healthcare, aligned with global trends in natural product utilization and sustainable therapeutics.
Indexed as
Identifiers
40932545What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.